Daniel Alvarenga Fernandes

Dr. Daniel Alvarenga Fernandes


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Radiologia Brasileira
Verified
Journal Article
Open access
PDF file
MBMarcela Leonardo Barros
Marcela Leonardo Barros
DFDaniel Alvarenga Fernandes
Daniel Alvarenga Fernandes
EMEnaldo Vieira de Melo
Enaldo Vieira de Melo
RPRoseane Lima Santos Porto
Roseane Lima Santos Porto
MMMaria Carolina Andrade Maia
Maria Carolina Andrade Maia
CPCarlos Umberto Pereira
Carlos Umberto Pereira
OBJETIVO: Identificar a prevalência de malformações congênitas do sistema nervoso central (SNC) e malformações associadas diagnosticadas pela ultrassonografia obstétrica. MATERIAIS E MÉTODOS: Estudo observacional, transversal, descritivo, em instituição de referência para gestações de alto risco. RESULTADOS: Malformações congênitas do SNC estiveram presentes sem outras malformações associadas em 65,78%, com a distribuição: hidrocefalia (37,5%), mielomeningocele (15%), encefalocele (12,5%), agenesia de corpo caloso (12,5%), anencefalia (12,5%), holoprosencefalia (7,5%), Dandy-Walker (7,5%), Arnold-Chiari (5,0%), hidranencefalia (5,0%), meningocele (5,0%), cisto aracnoideo (2,5%). Malformações congênitas de outros sistemas estiveram associadas às do SNC: craniofacial (73,9%), ortopédica (65,2%), cardiovascular (34,8%), geniturinária (30,4%), gastrintestinal (30,4%), respiratória (8,7%), sindrômica (8,7), oftalmológica (4,3%). A sensibilidade ultrassonográfica no estudo de malformações fetais do SNC foi 79,4%. A taxa de falso-negativos foi 20,5%. Dentre as limitações quantificáveis destaca-se o oligodrâmnio, presente em 25% dos falso-negativos. CONCLUSÃO: A ultrassonografia obstétrica possui boa sensibilidade no rastreio de malformações fetais do SNC, em especial com o aperfeiçoamento constante e domínio na utilização de métodos especializados, como o Doppler e a ultrassonografia volumétrica (3D/4D), contribuindo para firmar-se como modalidade de escolha nesta rotina. Complementar ao método, a ressonância magnética pode vir a fornecer subsídios para uma ainda melhor assistência perinatal.

29 August 2022 in Radiologia Brasileira
Verified
Journal Article
Open access
DFDaniel Alvarenga Fernandes
Daniel Alvarenga Fernandes
JMJoão Luiz Veloso Mourão
João Luiz Veloso Mourão
JDJuliana Ávila Duarte
Juliana Ávila Duarte
MDMariana Dalaqua
Mariana Dalaqua
FRFabiano Reis
Fabiano Reis
NCNelson Marcio Gomes Caserta
Nelson Marcio Gomes Caserta
Von Hippel-Lindau (VHL) disease is a monogenic autosomal dominant disorder with germline mutations of the VHL anti-oncogene on the short arm of chromosome 3 (3p25-26). It affects 1:36,000-50,000 individuals, with a penetrance greater than 90% at 65 years of age. Although of variable onset and presentation, with pleiotropism even among members of the same family who share a specific mutation, VHL disease usually manifests initially in young adults. It predisposes to the development of benign and malignant tumors of the central nervous system (CNS) and visceral organs. The clinical diagnosis of VHL disease can be made in the following circumstances: a) in patients with a family history of the disease and at least one of the tumors characteristic of it (e.g., retinal or CNS hemangioblastomas, clear cell renal cell carcinoma, pancreatic neuroendocrine tumors, and endolymphatic sac tumors); b) in patients with two or more CNS hemangioblastomas; c) or in patients with a retinal or CNS hemangioblastoma plus at least one visceral tumor characteristic of the disease, excluding renal and epididymal cysts. Imaging plays an important role in the diagnosis and follow-up of patients with VHL disease. This pictorial essay presents characteristic images of abdominal manifestations of VHL disease-related tumors that all radiologists should be aware of.

1 May 2022 in Radiologia Brasileira
Verified
Journal Article
Open access
JMJoão Luiz Veloso Mourão
João Luiz Veloso Mourão
LBLuiz Fernando Monte Borella
Luiz Fernando Monte Borella
JDJuliana Ávila Duarte
Juliana Ávila Duarte
MDMariana Dalaqua
Mariana Dalaqua
DFDaniel Alvarenga Fernandes
Daniel Alvarenga Fernandes
FRFabiano Reis
Fabiano Reis
Von Hippel-Lindau (VHL) disease is a rare, autosomal dominant inherited syndrome that affects the germline of the VHL gene, a tumor suppressor gene. VHL disease is characterized by the multisystemic development of a variety of benign and malignant tumors, especially in the central nervous system (CNS). Such tumors include retinal and CNS hemangioblastomas, as well as endolymphatic sac tumors. The various tumor sites are responsible for the diversity of signs and symptoms related to the disease. The mean age at symptom onset is 33 years. Despite medical advances, the average life expectancy of patients with VHL disease is 49 years. Imaging plays a pivotal role in the clinical diagnosis and is essential to the follow-up of patients with VHL disease. This pictorial essay describes characteristic CNS manifestations of VHL disease-related tumors that all radiology residents should be aware of.

1 April 2016 in Radiologia Brasileira
Verified
Journal Article
Open access
DFDaniel Alvarenga Fernandes
Daniel Alvarenga Fernandes
RKRicardo Yoshio Zanetti Kido
Ricardo Yoshio Zanetti Kido
RBRicardo Hoelz de Oliveira Barros
Ricardo Hoelz de Oliveira Barros
DMDaniel Lahan Martins
Daniel Lahan Martins
TPThiago José Penachim
Thiago José Penachim
NCNelson Marcio Gomes Caserta
Nelson Marcio Gomes Caserta
We present a case of immunoglobulin G4 (IgG4)-related disease with pancreatic and extrapancreatic involvement, including the biliary and renal systems. Given the importance of imaging methods for the diagnosis of IgG4-related disease and its differentiation from pancreatic adenocarcinoma, we emphasize important abdominal computed tomography and magnetic resonance imaging findings related to this recently recognized systemic autoimmune disease.

7 July 2025
Verified
Journal Article
Open access
DFDaniel Alvarenga Fernandes
Daniel Alvarenga Fernandes
DBDaniel Bohn
Daniel Bohn
PPPedro Antune da Silva Pereira
Pedro Antune da Silva Pereira
MMMila Mucci
Mila Mucci
VMVittor Hugo Andrade Marques
Vittor Hugo Andrade Marques
IBIlka de Fátima Santana Ferreira Boin
Ilka de Fátima Santana Ferreira Boin
The aim of this study was to investigate the diagnosis of sarcopenia in chronic liver disease by opportunistic computed tomography screening using the Psoas Muscle Index method as a predictor of mortality after liver transplantation. We systematically searched PubMed, Scopus, and Cochrane Central Register of Controlled Trials from July 2014 to July 2024. We restricted inclusion in this meta-analysis to observational studies and clinical trials on adult patients with chronic liver disease diagnosed with sarcopenia by computed tomography undergoing liver transplantation or on a waiting list. We included the one with a larger sample size for studies with overlapping populations. We excluded studies with therapeutic interventions, animal experiments, cell-line studies, editorial pieces, commentaries, review articles, and case reports. After the removal of duplicate records and ineligible studies, 163 remained and were thoroughly reviewed based on inclusion criteria. Of these, a total of 11 studies were included in qualitative synthesis and four studies were included in quantitative analysis (meta-analysis), comprising 382 patients. Patients with muscle mass loss after liver transplantation diagnosed by computed tomography scan using the Psoas Muscle Index method had a 4.1 times higher risk of death than non-sarcopenic patients (random-effects model: OR 4.1386; 95%CI 2.4215-7.0730; p<0.0001). Interpretatively, a scale with an I2 value close to 0% indicates no heterogeneity. The other criteria also did not reject the hypothesis of homogeneity among the articles. Patients with muscle mass loss diagnosed by computed tomography using the Psoas Muscle Index method had a fourfold increased mortality risk after transplantation. The findings reinforce the need to identify sarcopenic patients preoperatively to optimize liver transplantation outcomes. Using the Psoas Muscle Index, an opportunistic diagnosis by computed tomography scan can be helpful in this setting.

2 June 2024 in Clinical Toxicology
Verified
Journal Article
Open access
DFDaniel Alvarenga Fernandes
Daniel Alvarenga Fernandes
MJMarília Assunção Jorge
Marília Assunção Jorge
AFAndrea de Melo Alexandre Fraga
Andrea de Melo Alexandre Fraga
FRFabiano Reis
Fabiano Reis
Lead poisoning in childhood remains an important public health concern. We highlight the radiological findings in a patient with a high blood lead concentration. A 7-year-old girl presented to hospital with abdominal pain, nausea, and asthenia. Laboratory tests showed severe hypochromic microcytic anemia, punctate basophilic stippling of erythrocytes, and a blood lead concentration of 880 µg/L (4.3 µmol/L). Radiographs of the femur, tibia, and fibula demonstrated dense metaphyseal bands ("lead lines"). On cranial computed tomography, we observed multiple speck-like and curvilinear hyperdensities involving subcortical regions, putamen, and left cerebellar hemisphere. In patients with lead poisoning, imaging of the brain and bones may show characteristic features. These imaging findings may point to the diagnosis of lead toxicity when these radiographic findings are discovered during the evaluation of vague complaints such as abdominal pain or mental status changes or when a blood lead concentration is not readily available.